The intra-membrane aspartyl protease γ-secretase (GSEC) cleaves single-span transmembrane helices including the C-terminal fragment of the amyloid precursor protein (APP). This substrate is initially cleaved at the -site followed by successive processing (trimming) events mostly in steps of three amino acids. GSEC is responsible for the formation of N-terminal APP amyloid-β (Aβ) peptides of different length (e.g. Aβ 42 ) that can form aggregates involved in Alzheimer's disease pathogenesis. The molecular mechanism of GSEC-APP substrate recognition is key for understanding how different peptide products are formed and could help in designing APP-selective modulators. Based on the known structure of apo GSEC and the APP-C99 fragment we have generated putative structural models of the initial binding in three different possible modes using extensive Molecular Dynamics (MD) simulations. The binding mode with the substrate helix located in a cleft between the transmembrane helices 2 and 3 of the presenilin subunit was identified as a most likely binding mode. Based on this arrangement the processing steps were investigated using restraint MD simulations to pull the scissile bond (for each processing step) into a transition like (cleavable) state. This allowed us to analyze in detail the motions and energetic contributions of participating residues. The structural model agrees qualitatively well with the influence of many mutations in GSEC and C99. It also explains the effects of inhibitors, cross-linking as well as spectroscopic data on GSEC substrate binding and can serve as working model for the future planning of structural and biochemical studies.
INTRODUCTION
The intra-membrane aspartyl protease γ-secretase (GSEC) is a hetero-tetramer, consisting of the proteins nicastrin (NCT), presenilin (PS), anterior pharynx defective-1 (APH-1) and presenilin enhancer-2 (PEN-2). [1] [2] [3] [4] Presenilin with its nine transmembrane domains (TMDs), forms the catalytically active subunit of GSEC and contains the two active site aspartate residues, D257 and D385. 5 Nicastrin, with 709 amino acids (AA), the largest of the GSEC proteins consists of one TMD and a large soluble ectodomain (ECD). The majority of the available literature attributes two main functions to NCT: Stabilizing the GSEC complex 6 and preventing the inadvertent cleaving of non-substrates by impeding formation of the enyzme -substrate (E-S) complex, due to steric clashes between the ECDs of NCT and the (non)substrate. [1] [2] [3] The roles of the two other proteins, 7 APH-1 and PEN-2 involve the maturation of PS 4 (PEN-2) and scaffolding 8 (APH-1).
GSEC cleaves single-span transmembrane helices and so far more than 90 GSEC substrates have been uncovered. 1 The most prominent of these substrates is C99, the C-terminal fragment of the amyloid precursor protein (APP). C99 is generated by β-secretase mediated cleaving of the extracellular domain of APP. 9 After this pre-processing step, C99 can get into contact with GSEC and is then cleaved several times: At first C99 is reduced to a 49 (or 48) amino acid long fragment by an endo-peptidase step (also termed -cleavage), cleaving away the "amyloid precursor protein intracellular C-terminal domain" (AICD). Next, a succession of exo-peptidase cuts (ζ-and γ-cleavage) yields several mostly trimeric peptide fragments (from the C-terminus) as well as N-terminal amyloid-β (Aβ) peptides of different length. 10 The main Aβ product is the 40 amino acid long Aβ 40 . 10, 11 Several mutations and changes in temperature or membrane composition can shift this balance towards the production of amyloids that contain more amino acids 12, 13 -mainly Aβ 42 , but also even longer variants are obtained.
Although Aβ 40 is known to form aggregates, 14 the even more fibrillogenic Aβ 42 has been identified to be the main component of the plaques found in post-mortem brain tissue of Alzheimer's disease (AD) patients. 15, 16 These circumstances link both, C99 and GSEC closely to AD, the most common cause of dementia 17 and puts them into the spotlight for the development of novel therapeutic strategies.
One possible approach is to prevent the production of overly aggregation prone (=longer) Aβ peptides in the first place. Thus, the main question regarding C99 processing concerns the mechanism(s) leading to the generation of such longer Aβ variants. Many experimental studies strongly suggest (1) that mutations at specific residues, either in GSEC or in C99 can influence the location of the (initial) -cleavage site 2, 18-20 and (2) that while processing as an exo-peptidase γ-secretase, cuts the Aβ n fragment preferentially in steps of three consecutive residues. 19, 21, 22 This indicates that two different major Aβ n production lines exist: One starting from Aβ 49 ( -cleavage between C99 residues 49 and 50) and one where Aβ 48 forms the endo-peptidase product ( -cleavage between C99 residues 48 and 49). The first production line then leads in steps of three amino acids to Aβ 46 , Aβ 43 and finally to Aβ 40 which subsequently dissociates from the enzyme. The more pathogenic production line includes Aβ 45 and Aβ 42 where processing ends, releasing a longer end product into the extracellular matrix.
Complimentary, the sequential processing model suggests that some of the known familial Alzheimer's disease (FAD) -causing mutations lead to a destabilization of the Aβ n -GSEC complex which subsequently leads to the production of longer amyloids. 13, 23 In recent years, significant progress has been made in the investigation of γ-secretase. For instance, the CryoEM structure of GSEC (in different conformational states) 3, 4 has been solved and invaluable insights concerning the role of crucial C99 and GSEC mutations have been gained. 13, 18, 19, [24] [25] [26] However, important pieces of the puzzle surrounding Aβ production are still missing: Above all, the molecular mechanisms of how C99/PS mutations or GSEC modulators 23, 27 influence the outcome of C99 processing are not yet fully uncovered. This prevents rational, structure-based approaches to drug design and the development of new therapeutic strategies as well. Furthermore, the mechanism responsible for the repositioning of the Aβ n processing intermediates is not well understood.
Many of these issues could be addressed with a structure of the GSEC-C99 complex. Although not yet available, a number of studies have provided circumstantial evidence as to where the main GSEC-C99 interaction site might be located: Experimental investigations, such as photo-affinity mapping, have shown that C99 binds predominantly to the N-terminal Figure 1 : a) Cartoon representation of the structure of γ-secretase (PDB:5FN3 4 ), consisting of nicastrin (NCT, green), presenilin (PS-1, blue), anterior pharynx defective-1 (APH-1, yellow) and presenilin enhancer-2 (PEN-2, brown). A co-purifying helix (red) bound in the cavity formed by TMDs 2, 3 and 5 is also shown. b) Three potential substrate entry routes towards the active site of PS-1 (blue cartoon, view perpendicular to the membrane plane, the approximate location of active site is indicated as yellow dot). In Model 1 (black arrow), the C99 substrate enters between TMD 2 and 3 and ends up in the cavity formed by TMDs 2, 3 and 5. The blue arrow depicts Model 2, while Model 3 where C99 interfaces with TMDs 6 and 9, is shown as a red arrow.
domain of PS-1. 28 Another very important hint has been given by a co-purifying helix in two of the reported CryoEM structures by Bai et al.: 4 While the exact nature of the amino acid chain could not be elucidated, its position in a cavity, formed by TMDs 2 3 and 5 hints at a possible helix binding site in PS-1 (see also figure 1a ). Other experimental studies, however, suggested that C99 may interface with TMDs 2, 6 and 9. 29 Recent molecular dynamics (MD) simulations have revealed that the cavity formed by TMDs 2, 3 and 5, but also TMDs 2, 6 and 9 could be possible binding sites for hydrophobic species. 30 Then again, other theoretical studies favored TMDs 2 and 6 as entry site 31, 32 for C99. All this data reduces the number of potential substrate entry (and binding) sites to three likely positions shown in Figure 1b .
In the present study we performed atomistic µs-timescale molecular dynamics simulations starting from the three possible GSEC-C99 complex geometries. By taking into account known structural data and through free energy calculations as well as interpretation of mutational and other experimental data we identified a most likely C99 binding site in the cavity formed by TMDs 2, 3 and 5. We then conducted µs-timescale simulations of the putative GSEC-C99, Aβ 49 , Aβ 46 and Aβ 43 model complexes in order to profile key interaction sites and to gain insight into the mechanism of Aβ n processing. This allowed us to construct a working model of Aβ n processing, interpret the effect of mutations and to discuss an additional possible functional role of nicastrin.
RESULTS AND DISCUSSION

Identifying the main substrate binding interface
Putative models for the entry of C99 towards the active site of GSEC were generated by restraint MD simulations to initially bring the -cleavage site on C99 close to the active site, followed by extensive unrestraint simulations (see Methods for details). Simulations were started from three initial C99 placements resulting in models 1, 2 and 3 ( Figure 2 ). However, in none of the simulations the sites remained in close contact with the catalytically active centers after removing the restraints: The centers of mass of L49/V50 (backbone) and D257/D385 (sidechain) were on average separated by 16.2 ± 0.7Å (Model 1), 9.9 ± 0.6Å (Model 2) and 15.9 ± 1.0Å (Model 3). This indicates that the investigated complexes represent resting states (with C99 positioned at exo-sites) occurring prior to the conformational change which guides the scissile bonds closer to the active site. However, the relatively large distance between the C-terminus of the substrate helix in Model 1 could explain why small transition state analogues (in contrast to inhibitory helices, see discussion in the final paragraph of the results section) cannot prevent the formation of the E-S complex: 33, 34 In the resting state, the N-terminus of C99 binds in the same cavity as a helical inhibitor is expected to and therefore both peptides would compete for the same binding site. The large space between the C-terminus of C99 and aspartates 257 and 385, however, could allow a small molecule inhibitor to access the active site without displacing the substrate, hence both molecules could bind at the same time.
Even though simulation trajectories of more than 3500ns have been generated, no conformational changes between the resting state and a putative transition state have been sampled.
This suggests that such rearrangements are either very slow or very rare events and may be the reason for why C99 cleavage by GSEC occurs in time-scales of minutes. 1, 35 Since it is impossible to produce simulation trajectories of sufficient length, we instead used steered MD to force the system into transition-like states for all investigations presented in the next sections.
In the simulations of models 1 and 2, the enzyme-substrate-complexes remained stable throughout the 3µs sampling period. In the Model 3 trajectory, however, C99 was replaced by a POPC molecule at the TMD 6, 9 -interface around the 2µs mark, while the substrate molecule moved away from the active site towards TMD 2 of APH-1a (see also right panel on Figure 2 ). To measure differences in mobility, all frames of each simulation have been aligned according to the Cα atoms belonging to GSEC. From these aligned trajectories the mean B-factors of all Cα atoms belonging to C99 residues G37 to V47 (this was the C99 region that adopted a helical secondary structure in all three simulations) have been calculated. The results confirmed the visual inspection of the trajectories and showed that C99 A 2 ). Per-residue plots of the B-factor calculations can be found in the supplement.
From the obtained sampling trajectories of Models 1, 2 and 3, we also calculated the complex stability via MMPBSA and the values obtained clearly indicate that complex stabilization in Model 1, with −147.2 ± 0.5 kcal/mol is more favorable compared to models 2 (−97.7 ± 0.5 kcal/mol) and 3 (−108.2 ± 0.4kcal/mol). Please note that the large complex stabilization energies given in this section are due to the fact that entropy changes have been accounted for in the solvation model but not for complex formation, therefore the presented energies are closer to the binding enthalpy than the actual free energy (reasons for the omission of entropy changes are stated in the methods section). C99 in Model 3 did not stay at the starting position and thus it can be argued that the general stabilization energy between C99 and the PS-surface lies at around 100kcal/mol (in absolute numbers). The complex stabilization energy of Model 2 is slightly lower than 100kcal/mol, which could be explained by the N-terminal loop region of C99: In models 1 and 3, the Over 200 FAD causing mutations, affecting more than 130 different residues, have been reported on www.alzforum.org and it is likely that at least some of these directly steer E-S complex formation, stability or the positioning of the -site. In order to assess the potential of each model to explain the mode of action of these mutations, we counted the mean number of mutation sites that were within 5Å of C99 in each system. With on average 23 residues, Model 1 is in direct contact with a way higher number of mutation sites than either Model 2 (average of 12) or Model 3 (average of 11), indicating that the substrate binding mode in Model 1 may be more susceptible to mutations and thus could better explain experimental findings.
It has been well established that GSEC exists in at least two functional states: 4 active and inactive. Recent MD investigations indicate that GSEC can freely switch between these two conformations. 30, 36 The two states are characterized by the distance between the active site aspartates, D257 and D385. As can be seen on table 1, presenilin in the Model 1 simulation is in a catalytically active state in a majority of sampled frames, while models 2 and 3 occupy the inactive state most of the time. Even though this finding can be due to non-exhaustive sampling of the phase space of each system, it would make sense that the binding of a sub-strate molecule at the active site leads to a higher probability for an enzyme to occupy the active conformation. The presence of a co-purifying helix in some of the CryoEM structures published by Bai et al. 4 is further evidence that Model 1 represents a likely C99-GSEC complex.
Two arguments speaking against TMDs 2 and 3 forming the entry to the active site in the TMD 2, 3, 5 -cavity are (1) the short loop connecting TMDs 2 and 3 and (2) the shorter -site distances in the Model 2 simulation, indicating that the conformational change leading to the transition state would have to be less pronounced in the Model 2 case.
The first argument, invokes two requirements for complex formation of (uncleaved) C99 with GSEC: Firstly, the substrate, since it is too long to fit into GSEC in its entirety, has to be bent in order to allow the scissile bond to get into contact with the active site. After the initial -cleavage removes the AICD, the remaining Aβ n peptide fits the cavity without bending. In the Model 1 simulation, C99 is kinked in the region between G37 and V40, an area often referred to as the "hinge region". 2 This requirement for helix bending may explain why γ-secretase substrate flexibility has very often been found to be connected to enzyme binding and proteolytic activity. 2, [37] [38] [39] [40] [41] The other requirement is that the distance between TMDs 2 and 3 increases, so that a protein helix can enter the active site. In the Model 1 simulation, TMD 2 moves away from TMD 3 as C99 is pulled inside the cavity. This fits the experimental 3, 4 and theoretical findings 30, 42 attributing heightened mobility and flexibility to TMD 2 (including the N-terminus of TMD 3) and confirms its role as substrate entry gate.
In case of the second argument one has to note that the shorter -D257/D385 distances of Model 2 are only caused by the fact that the binding interface is spatially closer to the active site than in the other models. Conformationally there is nothing to suggest that C99 is more "ready to be cleaved" in Model 2 than it is in Model 1. In Model 2 the scissile bond still has to traverse inside the PS "pore" to get into contact with aspartic acids 257 and 385.
However, the putatively easier access to the active site and less stable complex in Model 2 could also be taken as a hint for the presence of two different active binding sites: One (Model 2) for the initial cleavage and a second (Model 1), where the γ and ζ processing steps take place. The binding cavity of Model 1 is not easily accessible from the TMD 2, 6 interface since the extracellular loop 1 (between TMDs 1 and 2) blocks the direct path. In order to migrate from the Model 2 site to the binding cavity, the substrate's N-terminus would have to somehow move underneath loop1 without becoming entangled, which for steric reasons is very unlikely and thus also highly impractical. The only realistic entry path would be dissociation from the TMD 2, 6 interface and migration across the surface of PS 1 until the TMD 2, 3 interface is reached. Even though both pathways seem to be very improbable, we still think that at least the second pathway (migration across the enzyme surface) can not be completely ruled out and further (experimental) investigations are necessary to assess this possibility more closely. For efficiency reasons, the Model 1, 2 and 3 simulations have been conducted in absence of the NCT ECD, however, a superposition of Model 1 with the complete GSEC structure indicated that if C99 binds at the Model 1 location then it is very likely also in contact with a small patch of the NCT ECD, ranging from S241 to E245. This contact region between NCT and the substrate coincides with the interface between a co-purified helix and nicastrin found in some of the CryoEM structures published by Bai et al. 4 Therefore, the Model 1 binding mode would also explain best NCT-C99 interactions that have previously been suggested by experiment. 28, 43 Even though such interactions cannot be completely ruled out for Model 2, they are much more unlikely, due to the absence of a stable NCT-PS interface at TMDs 2 and 6. For all the reasons discussed above, in the subsequent parts of the manuscript we assume that Model 1 resembles most closely a Aβ n -GSEC complex with the -cleavage site in close proximity to the GSEC active site and discarded the two other hypotheses. We also included the nicastrin ectodomain because of the putative PS-NCT interface.
Nicastrin stabilizes C99 binding in Model 1
Since we simulated all GSEC-Aβ n complexes twice, once in presence and a second time in absence of the nicastrin ectodomain, we were able to compare complex stabilities ( Table 2 ).
The Aβ n -GSEC complexes were consistently more stable in the presence of nicastrin (mean ∆∆G of ∼ -30 kcal/mol). In simulations missing the NCT ECD, the N-term formed additional interactions with the loop 1 region. However, the MMBPSA calculations indicate that the stabilizing influence of the ECD outweighs the effect of additional PS-loop1-Aβ n interactions.
Hence, it is likely that the role of NCT also lies in the stabilization of the E-S complex.
The substrate processing mechanism
In the GC99 simulation, the substrate ended up exactly at the same location as the copurifying helix in the structures published by Bai et al. 4 (a superposition of both structures can be found in the supplement).
In order to investigate further processing of the C99 substrate we generated model structures Generally, two different modes of action are possible: The helix could unwind and elongate so that the scissile bond can get into contact with the active site aspartate residues or the substrate could slide deeper into the binding cavity, thereby keeping its helical structure. As can be taken from figure 3, the simulations showed that between each cleavage step, the substrate is pulled deeper into the binding cavity of PS. However, the data also suggests that there is an N-terminal anchoring region that remains in place while Aβ n is processed.
Furthermore, the distance plot on figure 3 indicates that at the last processing step, from Analysis of the extend of helicity of the substrate molecules, measured via characteristic hydrogen-bonds, in our simulations advocate for a combined sliding/unwinding mechanism:
In figure 4a, residue n in frame i has been deemed helical if its backbone amide group either functioned as an H-bond donor to the n-4th residue or as an H-bond acceptor for the n+4th residue. A distance-based criterion has been used to determine the existence of H-bonds (distance between donor-H and acceptor O < 3Å). The helicity calculations clearly show that every processing intermediate is destabilized at the C-terminus and considerably less helical than its predecessor. Also, the N-terminus is unwinding during substrate processing which is necessary for the anchor region to stay in place while the remaining helix is moving further into the binding site. While C99, Aβ 49 and Aβ 46 remain relatively helical in the region spanning from G29 to G38 (all residues occupy the helical state to nearly 100%), the helix of Aβ 43 is very distorted. The green plot on figure   4a shows that even the more stable section between residues 30 and 36 is only 60-80% helical.
The perturbation of the helicity is also indicated by the mean backbone (BB) hydrogen bond lengths (from the nth to the n-4th residue) plotted on figure 4b.
If the information on figures 3 and 4 is combined, it is evident that the extend of sliding and unwinding is not the same in all processing steps: Cleaving C99 to Aβ 49 causes strain in the N-terminal region (N27, K28 are less often helical) and unwinding at the C-terminus from residue 42 on. K28 on the other hand, edges just 1.8Å closer to the active site of PS, while the overall helicity decreases by 4.5% (see also table 3).
The processing step leading to Aβ 46 , however, is above all characterized by a 5.0Å K28 displacement towards the PS TMDs. The mean helicity decreases by 13.2%, which is largely due to the helix opening in the C-terminus. The N-terminus is even slightly more helical than in simulation GAβ 49 (see figure 4a ). The first one is the already discussed N-terminal anchor, which on one hand prevents complete dissociation of the E-S complex but on the other hand also keeps the N-terminus from sliding deeper into the membrane. Another explanation can be found by examining how Aβ n residues K28 and N27 interact with their environment:
In all conducted simulations, these residues, even though being close to GSEC, predominately interacted with the phosphate headgroups of POPC via Coulombic forces. This finding confirms the proposed role of K28 as an anchor in the lipid bilayer. 44 According to our measurements, K28 is pulled inside the membrane helix while maintaining interactions with water molecules and the POPC headgroups. Due to the length of the side chain this seemed to work well for GAβ 49 and GAβ 46 but in GAβ 43 , the amino group moved already towards the hydrophobic region, still maintaining polar interactions. This relocation distorted the membrane surface and pulled polar residues and water to the bilayer, thereby forming a hydrophilic sphere around the amino group of K28 (see figure 5 , left panel). Evidently, this is energetically unfavorable and indicates that cleaving steps requiring such rearrangements are impaired by high reaction barriers.
The scissile bond has been pulled towards the active site via COM distance restraints in the simulations, therefore some interactions necessarily need to disrupt in order to allow close contacts at the active site. Our evaluation of the GAβ 43 simulation implies that the hydrogen bonding network in the helical region was weaker than the anchoring effect of K28 and instead of moving further into the cavity, the secondary structure of GAβ 43 began to change. Since this too involves a significant energetic penalty it seems plausible to conclude that it is a major reason why APP processing usually stops after cleaving to Aβ 40 .
To quantify the role of the juxtamembrane region of Aβ n peptides, we conducted MMPBSA -based in-silico alanine-scans for all (eligible) amino acids present in our substrate model ( Figure 5, right panel) . Indeed, most substitutions to alanine are predicted to destabilize the complex. However, the polar and charged residues situated at the substrate's juxtamemrane region clearly have an adverse effect on the stability of the GSEC-Aβ n complexes:
While K28 and N27 also destabilize the E-S complex in GC99 and GAβ 49 , results for GAβ 43 and GAβ 46 predict a substantial increase in substrate-enzyme affinity for K28A and N27A
mutations, suggesting that the insertion of the substrate molecule further into the membrane is energetically unfavorable. K28 acting as an anchor, necessitating higher activation energies Right panel: In-silico alanine scans of all eligible residues from V12 to M51. Results for the GC99 case are shown as orange bars, GAβ49 red, GAβ46 blue and GAβ43 green. A negative ∆∆G value indicates complex destabilization upon mutation into alanine, while a positive value signifies that the Ala-mutant interacts more favorably with the enzyme. The gaps in the data set are due to the fact that residues of type Gly or Ala can for methodological reasons, not be used for in-silico alanine scans. and the fact that K28A mutations stabilize the complex (increasing E-S complex life time) may therfore explain why the K28A mutation in experimental studies leads to very short (<40AA) Aβ peptides. 44 We were also able to investigate how complex formation impacts substrate helicity: According to our evaluations, shown on Figure 4a , free C99 (colored in black) remains helical up until residue L52. (while the secondary structure of K53 is more ambiguous). Bound to GSEC, however, C99 begins to unwind at T48 and by taking the standard deviations in Figure 4b into account as well, one can argue that helix destabilization begins already at I45.
This data is in good agreement with a recent NMR study of the transmembrane domain of APP 45 that investigated the amide chemical shift perturbation caused by binding to the enzyme. The authors observed very subtle hydrogen bond destabilization beginning at V39, an increase at around V44 to T48 and a jump in chemical shift perturbation at residue L49.
Qualitatively, this fits very well to the observed weakening of hydrogen bonds in our simula- tions. At the N-terminus, the study reported that A30 exhibited weaker hydrogen bonds in free C99 than in bound form. Figure 4b shows that this is also the case in our simulations. A similar finding, concerning residues G33 and L34 could not be replicated, since the hydrogen bonds were stable in both (GC99 and free C99) simulations.
The continuous unwinding of the substrate helix may be attributed to the presence of water molecules at the Aβ n C-terminal region. In order to test this hypothesis we have calculated the mean number of water molecules close to the backbone of residues V44 to L52 in simulations C99 and GC99 or the nine C-terminal residues in simulations GAβ 49 , GAβ 46 and GAβ 43 , respectively ( Table 4 ). The results indicate that the number of water molecules is lower in the simulation of free C99, compared to the complex bound forms. This is due the fact that the binding site of C99 which is situated within the TMDs of PS acts like a pore that allows water molecules to enter the otherwise hydrophobic intra-membrane region. The hydration numbers suggest that helix unwinding is at least partially mediated by the presence of water molecules in the active site of GSEC. Binding to the enzyme, however, can also be expected to have a distinct effect on the helicity of the substrate.
1.4 Aβ n is in close contact with many known FAD-mutation sites.
As already established, Aβ n is in proximity to a large number of FAD-mutation sites located on PS when binding to the cavity formed by TMDs 2 3 and 5. For further investigation, we re-evaluated the mutation site proximities for the more representative simulations GC99, The simulations suggest that in our model a very large number of crucial PS residues is close to the substrate during all steps of proteolytic processing. Naturally, C99 being longer than the processing intermediates is in contact with more mutation sites than the latter. However, the large number of shared sites indicates that the processing pathway may not exclusively Table 5 : Known FAD-causing mutation sites that are in close contact with Aβn. Only mutation sites that are in at least 30% of evaluation frames within 5Å of a substrate residue in at least one of the simulations are shown. The given percentages correspond to the number of evaluation frames in which the respective residue was within 5Å of the substrate. * Part of the GXGD motif (L383 is not a known FAD mutation site, it has been shown, however, that L383X mutations influence GSEC behavior as well 26 ). † The 5FN2 PDB stucture that was used as starting template for the simulations featured a Y256T mutation. Residue names printed in bold font are situated on the C-terminal fragment of PS.
be determined at the endo-peptide stage but also during γ-or ζ-cleavage. 19 In addition to FAD-causing mutation sites, also the GXGD motif is in proximity of a number of Aβ n residues. Extensive mutagenesis studies 25, 26, 46 have shown that increasing the size of the Gly residues and/or mutation of the x-residue in the GXGD motif has a severe impact on GSEC processivity, pathogenicity a well as substrate selectivity. This hints at the existence of key interactions between enzyme and substrate in this area.
Recently, Fukumori et al. 28 Overall, the presented model features many close substrate-enzyme interactions at sites that are known to be crucial for the cleaving of C99, lending credibility to its ability to elucidate how PS mutations impact the catalytic properties of GSEC.
Conclusions
We have performed twelve µs-timescale simulations of free C99, as well as various GSEC-Aβ n complexes and identified the binding cavity formed by PS TMDs 2, 3 and 5 to be the most likely binding site for the substrate. In this pocket, the substrate is in contact with the Nand C-terminal fragments of PS and additionally, with the extracellular region of nicastrin.
Furthermore, the simulations and subsequently performed MMPBSA free energy estimations suggested that NCT acts as a binding partner for Aβ n during processing.
In addition to the C99-GSEC complex, also the processing intermediates Aβ 49 , Aβ 46 and Aβ 43 have been investigated. This allowed us to draw conclusions about the possible mechanism of substrate repositioning in the active site and it was revealed that a combined unwinding/sliding mechanism is responsible for repositioning the scissile bond to induce subsequent hydrolysis steps. Regarding the mechanism, we also found that even though large parts of the helices are repositioned/unwound during processing, many residues belonging to the N-terminal loop region of the Aβ n substrate peptides maintained their interactions with PS/GSEC throughout all simulations. This finding strongly supports the existence of a permanent N-terminal anchoring region as has been suggested previously. 13 At least from a mechanistic point of view this binding area is an interesting candidate for modulator binding, since it remains topologically unaltered for the duration of C99 processing.
Based on previously existing knowledge and findings in this study, we propose that there are four different kinds of GSEC/APP mutations modulating the outcome of C99 processing:
(1) Mutations that (de)stabilize the GSEC-Aβ n complex, situated at the interface between enzyme and substrate. These mutations influence E-S complex lifetimes which in turn leads to Aβ peptides of different length. (2) Mutations on either GSEC or APP, leading to a shift towards a production line terminating at Aβ 42 which dissociates from the enzyme before it can be cleaved to Aβ 39 . This work indicates that the dissociation is likely caused by reduced N-terminal interactions, strain of the remaining helix and the energetically unfavorable pulling of polar species inside the membrane region. (3) Mutations of K28/N27 on C99 to apolar species have been shown to lead to exceptionally short products. 44 Our investigations suggest (and confirm) that K28/N27 anchor Aβ n helices to the headgroup region of the bilayer (a depiction of K28 interacting with two POPC molecules is provided in the supplement). During processing these very polar/charged side chains are pulled inside the membrane region which is energetically unfavorable. Removing these barriers aids the repositioning of very short intermediates and thereby increases the reaction rates of the later stages of C99 processing.
(4) Mutations on PS that lead to a change of processivity by impacting the probability of PS to occupy the catalytically active conformation, hence changing the intervals between two cleavage steps.
Another topic controversially discussed in the context of APP processing is APP homodimerization. [51] [52] [53] Our study strongly disfavors the proteolytic cleavage of APP homodimers, as the binding model suggests that there is not enough space at the active site cavity to accom- Table 6 : Overview over the simulations that have been conducted in the course of this investigation. "GSEC" indicates if the TMDs of GSEC were present in the simulation box, while ECD indicates the presence (or absence) of the NCT ECD. The parenthesis indicate that the simulation has been carried out twice, once in presence of the ECD and a second time in its absence (the absence of the ECD is denoted by a '*' in the simulation name).
modate such dimers.
In this study we propose a working model of the APP-GSEC complex in atomistic detail.
The presented binding mode is based mainly on three known structural properties: The apostructure of γ-secretase, 4 an NMR structure of C99 37 and that at some point of substrate binding the scissile bond has to be in contact with the active site. Although other putative complex geometries cannot be completely excluded, the present working model is able to confirm and explain several well established experimental findings. Hence, the model can serve to guide mutagenesis, disulfide-and other cross-linking studies of the Aβ n -GSEC complex and encourage investigators to use the model to challenge and improve the proposed binding mode of the γ-secretase-Aβ n complex.
MATERIALS AND METHODS
In the course of this study, 12 simulations of C99 and C99-, Aβ 49 -, Aβ 46 -, Aβ 43 -GSEC complexes have been performed. An overview is provided in Table 6 .
Starting structures
The γ-secretase structures used in the simulations have been taken from already equilibrated structures of the µs -timescale production trajectories of a study on the apo-structure of GSEC, 30 which in turn were based on the PDB structure 5FN2 4 (RMSDs of the apo-state simulations can be found in the supplement). The starting conformation of the C99 fragment (residues V12 to Y57) used in this investigation has been taken from PDB file 2LP1. 37 The substrate fragment used in the simulations is considerably longer than one of the shortest C99 chains that are known to be processed by GSEC (E22 to K55). 54 The simulation box of the C99 simulation has been created by first submitting the PDB file to the PPM- 55 and subsequently to the CHARMM-GUI -server 56, 57 to insert the lipid spanning part of C99 in a physically reasonable way into a POPC membrane. The protonation states of the titratable side chains were chosen according to their natural state at pH 6.5.
In a pre-equilibration step, target temperature and pressure were reached in a step-wise pre-equilibration phase, as suggested by the CHARMM-GUI server (details can be found in Supporting Information). After 500ns of equilibration, a 3000ns sampling trajectory was generated.
ACE and NME capping groups have been used for the N-and C-terminus of C99 in simulations C99, Model 1, Model 2, Model 3, GC99 and GC99*. In all other simulations, only the N-term of the Aβ n chain has been capped. In simulations containing GSEC, the N-termini of NCT, PS-1 and APH-1 were capped with ACE groups, while the C-termini of NCT and APH-1a
were terminated via NME. In all other cases the number of missing residues was so low that a charged tail was deemed to be more realistic than a capped one.
Generation of the GSEC-Aβ n complexes
The Model 1, 2 and 3 structures were generated by placing the equilibrated C99 chain close to the investigated binding surface on the outside of PS. The GSEC structure was taken from an equilibrated (3500ns long) simulation of the apo-conformation of GSEC, missing the ECD. 30 After 1000ns of free simulation, since the Model 1, 2, 3 simulations showed that the -site does not stay in contact with the active site for a substantial amount of time, we forced the groups that would be involved in the hydrolysis into a transition-state like conformation 58 (see also figure 7) . This enabled us to study the GSEC-C99 complex in the state in which it could also be cleaved. Therefore, the active site restraints remained active for the complete sampling phase (which again followed 500ns of equilibration).
The starting structure of the GC99 simulation (including the ECD) was constructed by taking the PS-C99 complex (discarding the rest of GSEC) from the Model 1 complex simulation and merging it with full GSEC. The full GSEC structure was taken from a snapshot of a 1000ns long simulation of the complete GSEC complex. 30 The two structures were merged by replacing the original apo-PS with the PS-C99 complex from the Model 1 simulation. Starting from this merged structure, the simulation protocol was exactly the same as for GC99*.
In both types of simulations -with and without the ECD, the shortened Aβ n chains were generated by deleting the residues that are removed by the enzymatic hydrolysis. Again, the systems (GAβ 49 , GAβ 46 , GAβ 43 ) were allowed to equilibrate for 1000ns and subsequently forced into transition-like states. These states were simulated for 3500ns and after discarding the first 500ns, the trajectories were used for evaluation. All proteins have been simulated in a 0.15M KCl solution to ensure a realistic, physiological environment.
Simulation Details
The simulations have been performed using the CUDA 59 accelerated version of PMEMD [60] [61] [62] -part of the AMBER16 package. 63 Proteins and lipids have been described by the AM-BER14SB 64 and Lipid14 65 force fields respectively, while the TIP3P 66 model has been used for water. The cut-off for Coulombic and other non-bonded forces were set to 8Å, all interactions beyond that were described by the particle mesh ewald method. 67 Periodic boundary conditions were used, with box sizes ranging from ∼ 400000 (C99) over ∼ 1700000 (Model 1, 2, 3) to ∼ 2200000Å 3 (GC99, GAβ 49 , GAβ 46 , GAβ 43 ). The target temperature for all simulations was 303.15K, using the Langevin thermostat 68 with a collision frequency of 1ps −1 .
The Monte Carlo barostat 69 was used to generate NPT ensembles with a target pressure of 1.0 bar. In order to achieve time steps of 4.0fs, the SHAKE 70 algorithm has been utilized in conjunction with hydrogen mass repartitioning. 71 Trajectory analysis was carried out using CPPTRAJ 72 (also part of the AMBER16 package) and VMD, 73 which was also used for visualizing the output and rendering the snapshots. We included further details regarding the COM restraints and pre-equilibration protocol in the supplement. With average Cα RMSDs (disregarding the highly mobile loop region between TMDs 6 and 7 in all simulations including GSEC) ranging from 2.4Å (GAβ 43 *) to 4.1Å (GC99) all simulated structures remained stable throughout the sampling phase (RMSD plots for all simulations can be found in the supplement).
Free Energy Calculations
Free energy calculations and alanine-scans have been conducted using the single-trajectory MMPBSA 74 post-processing method, utilizing the MMPBSA.py 75 program. An implicit membrane model has been employed in order to describe the system electrostatics as realistically as possible. The membrane has been assumed to be 34Å thick. This made sure that the permittivity of the region that was originally spanned by the POPC lipid tails, could be set to ε = 2.0 in the Poisson-Boltzmann implicit solvation treatment. 76 Our simulations showed that a large number of water molecules were level with the headgroup region of the membrane -especially in the cavity between PS and the GSEC ECD (which is void of lipids), therefore the phosphatidylcholine -region was included in the the aqueous layer (with ε = 80.0) of the model to ensure realistic electrostatic interactions between the N-terminus of Aβ n and GSEC. The internal permittivity (of the protein) has been assumed to be ε = 1.0.
The center of the membrane slab (in z-direction) was set to the mean value of the center of mass of the POPC bilayer in the respective trajectory and periodic boundary conditions have been used to ensure the a realistic treatment of the membrane. The ionic strength was set to be equal to the one in the explicit treatment (0.15M).
In every MMPBSA calculation, 1500 frames have been evaluated in order to generate reliable statistics. Due to the enormous system size, the computational expense of the implicit membrane treatment and the large number of MMPBSA calculations that were necessary for this study, no entropy corrections (beyond the intrinsic PBSA entropy terms) have been performed. Therefore, the presented energies cannot be directly compared to experimentally derived ∆G values.
Supporting Information
Additional pictures and simulation details are supplied in pdf format. 
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